Skip to content
DraconiticResearch
Search Sources API
210,423 studies31 sourcesUpdated 6 min ago

Oncology

5,311 studies490 in 7 days2,547 in 30 days

Filters
Type
Date
Clear

Latest

5,311 studies

  1. Twenty Years of Modern Rectal Cancer Care in Lithuania: Stage Migration, Evolving Treatment Patterns, and Improved Survival at a Tertiary Referral Centre.
    Rita Ambraziene, Laura Kairevice, Lina Puzauskiene +12
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textOncologyEurope PMC
  2. Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.
    Ece Sahin Hafizoglu, Ferhat Ekinci, Mustafa Sahbazlar +1
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  3. Longitudinal multi-omic profiling separates persistent from resolving sequelae of breast cancer treatment
    H. Noh, M. E. Brunkow, A. V. Carr +14
    medRxivPreprintCC BYFull textOncologymedRxiv
  4. Lymphatic Spread Patterns in HPV+ vs. HPV- Oropharyngeal Squamous Cell Carcinoma: A Multi-Center European Analysis
    Y. Perez Haas, R. Ludwig, E. L. Looman +9
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  5. Diagnostic Potential of Circulating CXCL13, CXCL14, and CXCL16 in Colorectal Cancer: A Preliminary Case-Control Study.
    Adrianna Romanowicz, Marta Łukaszewicz-Zając, Agnieszka Kulczyńska-Przybik +3
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  6. Acquired Chemoresistance in Colorectal Cancer: Therapy-Induced Signalling Adaptation, Cellular Plasticity and Mechanism-Guided Therapeutic Strategies.
    Dorota Bartusik-Aebisher, Izabella Wilk, Blassan P George +1
    CellsPeer-reviewedCC BYFull textOncologyEurope PMC
  7. Beyond Sulfation: Integrated Immunohistochemical, Genomic, and Proteomic Profiling Identifies PAPSS1 as a Potential Regulator of Breast Cancer Progression.
    Rabab Ahmed Ahmed Mohammed, Amina Ismaeel, Safa Alshaikh +3
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  8. Single-Cell and Multi-Omics Profiling of the Multiple Myeloma Immune Niche: From Bone Marrow Architecture and Metabolic Reprogramming to Immunotherapy Response.
    Katia Beider, Olga Ostrovsky, Arnon Nagler
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  9. Histological Subtype Provides Limited Prognostic Information in Grade 1 Invasive Breast Carcinoma: A Retrospective Cohort Study.
    Eleonore Locher, Lara Benning, Zsuzsanna Varga
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  10. Sequencing BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma: A Real-World Comparison of CAR T-Cell Therapy and Bispecific Antibodies.
    Osama M Younis, Sencer Goklemez, Carmel Awadallah +19
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  11. Temporal Trends in Six Major Cancers: Implications for Lifestyle-Based Cancer Prevention and Early Detection Across the Life Course.
    Itunu Sokale, Omar Rosales, Hashem El-Serag +4
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  12. Dynamic Multi-Phase-Fused Photon-Counting CT for Pre-TACE Feeding Artery Mapping and DSA Procedural Road-Mapping in Hepatocellular Carcinoma.
    Hao Chen, Hao Deng, Xin Wei +2
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  13. Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers
    Sarah Cogoluegnes, Sandra Kovachka, Thierry Dubois +7
    Translational OncologyPeer-reviewedCC BY 4.0Full textOncologyPharmacology & toxicologyHAL
  14. The Utility of Computed Tomography of the Chest at the Time of Induction Chemotherapy in Patients with Acute Leukemia
    Maro Ohanian, Fieke W. Hoff, Vikas Kundra +10
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  15. AI-Driven Multi-Omics Approaches for Deciphering Small-Cell Lung Cancer Heterogeneity Using Nucleic-Acid-Based Features
    Saman Zeeshan, Caila McVey, Shafaq Majeed +2
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  16. ZBTB1 Regulates Glycolysis and Chemotherapy Resistance Through Interacting with c-Myc in Triple Negative Breast Cancer
    Na Qian, Songyao Sun, Cong Ouyang +10
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  17. FABP5 regulates an immunosuppressive microenvironment in hepatocellular carcinoma through the NF-κB/PD-L1 axis
    Rui An, Shibing Hou, Min Hong +7
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  18. Efficacy and safety of T-DXd versus Other HER2-targeted therapies in second-line and later settings for HER2-positive metastatic breast cancer: A Bayesian network meta-analysis
    Yu Xiao, Jing Fu, Juan Li +1
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPharmacology & toxicologyPLOS
  19. Prognostic impact of postoperative complications among elderly patients with gastric cancer
    Kohei Matsuoka, Yuichiro Miki, Ryota Kawai +10
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologySurgery & anaesthesiaPLOS
  20. Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation
    Lele Chang, Yaxin Kang, Mingxuan Zhu +3
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  21. Tumor specific cytokine pattern explored in renal cell carcinoma
    Xu Chen, Zhuangyao Liao, Rochelle Wickramasekara +8
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPhysiologyPLOS
  22. Selective serotonin reuptake inhibitors and immune checkpoint blockade in solid tumors: A target trial emulation with pan-cancer transcriptomic analyses
    Po-Huang Chen, Ming-Shen Dai, Mao-Hsuan Huang +5
    PLOS MedicinePeer-reviewedCC BY 4.0Full textOncologyPLOS
  23. Early and Late Prognostic Factors in Patients with Resected Brain Metastases
    Dan M. Visarion, Ioana Petrescu, Viorel M. Pruna +1
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  24. The Novel Organic Arsenical PZ2 Exhibits Potent Anti-T-ALL Activity via ROS-Dependent Apoptosis and GABARAPL1-Induced Autophagic Cell Death
    Xian Zhang, Zhuping Chen, Yujiao Liu +1
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  25. Diagnostic accuracy of PET/CT parameters for noninvasive prediction of isocitrate dehydrogenase mutation status in glioma: a systematic review and meta-analysis
    Xulu Zhao, Yiran Chen, Zhi Zhang +3
    Translational Cancer ResearchPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC